Potential Alzheimer’s treatment to begin phase 3 trials

It was announced today that phase III clinical trials of a potential Alzheimer’s treatment, called LMTX, have begun in the UK. About 16 centres across the UK are expected to participate in the trials, which will involve people with mild to moderate stage Alzheimer’s disease.